Top Markets
Coin of the day
Nika Pharmaceuticals Inc. Nika Pharmaceuticals Inc.

Nika Pharmaceuticals Inc.

NIKA
Rank in Stocks #14183
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in... Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
Share Price
$0.41
Last synced: 2026-08-28
Market Cap
$429.91M
Change (1 day)
0.00%
Change (1 year)
-56.72%
Country
US
Trade Nika Pharmaceuticals Inc. (NIKA)

Category

Revenue for Nika Pharmaceuticals Inc. (NIKA)
Revenue in Aug 2026 TTM: 0
According to Nika Pharmaceuticals Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nika Pharmaceuticals Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors